Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Nanalysis Scientific's Sloan Ratio for the quarter that ended in Mar. 2026 was -13.92%.
As of Mar. 2026, Nanalysis Scientific has a Sloan Ratio of -13.92%, indicating there is a warning stage of accrual build up.
Nanalysis Scientific (OTCPK:NSCIF) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Nanalysis Scientific has a Sloan Ratio of -13.92%, indicating there is a warning stage of accrual build up.
Nanalysis Scientific Sloan Ratio % Related Terms
Nanalysis Scientific Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Nanalysis Scientific's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSCIF vs COHR, KEYS, GRMN: Sloan Ratio % Comparison
For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanalysis Scientific Sloan Ratio % vs Hardware Industry
For the Hardware industry and Technology sector, Nanalysis Scientific's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Nanalysis Scientific's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Nanalysis Scientific's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
Nanalysis Scientific's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was -1.553 (Jun. 2025 ) + -1.084 (Sep. 2025 ) + -0.528 (Dec. 2025 ) + -0.934 (Mar. 2026 ) = $-4.10 Mil.
Nanalysis Scientific's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was -1.147 (Jun. 2025 ) + -0.223 (Sep. 2025 ) + 1.921 (Dec. 2025 ) + -0.095 (Mar. 2026 ) = $0.46 Mil.
Nanalysis Scientific's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -0.272 (Jun. 2025 ) + -0.254 (Sep. 2025 ) + -0.345 (Dec. 2025 ) + -0.133 (Mar. 2026 ) = $-1.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanalysis Scientific (NSCIF) has a Sloan Ratio % of -13.92% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Nanalysis Scientific and its competitors.
Is Nanalysis Scientific's Sloan Ratio % too high?
Nanalysis Scientific's current Sloan Ratio % is -13.92%. Overall, Nanalysis Scientific has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanalysis Scientific's Sloan Ratio % compare to COHR and KEYS?
Nanalysis Scientific's Sloan Ratio % of -13.92% can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Hardware company?
A good Sloan Ratio % depends on the Hardware industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Nanalysis Scientific and its competitors. Nanalysis Scientific's current Sloan Ratio % is -13.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanalysis Scientific stock overvalued right now?
Based on GuruFocus' analysis, Nanalysis Scientific (NSCIF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.09 — trading 57% below its estimated fair value. The current Sloan Ratio % is -13.92%. Nanalysis Scientific's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Nanalysis Scientific (NSCIF), the current Sloan Ratio % is -13.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanalysis Scientific (NSCIF) Overvalued in 2026?
Based on GuruFocus' analysis, Nanalysis Scientific stock appears to be undervalued.
The current stock price of $0.09 is trading 57% below its estimated GF Value™ of $0.21.
GuruFocus considers Nanalysis Scientific to be Possible Value Trap.
Key valuation signals for NSCIF:
Sloan Ratio %: -13.92%
GF Value™: $0.21 vs. price of $0.09 (57% below fair value)
No single metric tells the full story. See the NSCIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanalysis Scientific Corp has two primary operating segments. Its first operating segment, Scientific Equipment, conducts scientific equipment manufacturing and sales, mainly as a patent-protected technology company that develops, manufactures, and sells magnetic resonance products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science, and medical applications. Its second operating segment, Security Services, focuses on providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. The majority of this segment consists of servicing a Crown Corporation of the Government of Canada, maintaining imaging and security equipment at international airports across Canada.
51GF Score
Get the complete analysis for NSCIF
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSCIF has been successfully added to your 
